Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its ...
Hosted on MSN2d
MSD acquires WuXi's vaccine facility in Dundalk for €500mThe Dundalk site was WuXi's first manufacturing investment in Europe and the company’s first investment of this scale outside ...
MSD's acquisition of the WuXi Dundalk site strengthens the company’s long-standing commitment to Ireland, bringing its ...
MSD has spent €500M acquiring a Dundalk vaccine plant and several other facilities around Ireland in an early year boost for ...
Irish Independent on MSN2d
MSD buy out WuXi Vaccines’ Dundalk plant in €500m dealThe pharmaceutical firm MSD is buying out the WuXi Vaccines manufacturing plant in Dundalk, in a €500m deal. The American company says that in addition to the 150 jobs at the Dundalk facility, it is ...
US pharmaceutical group adds eighth Irish manufacturing site to its network as it promises to deliver 1,000 jobs this year ...
Irish Independent on MSN2d
MSD Ireland takeover of WuXi plant ‘a tremendous vote of confidence in Dundalk’ says TaoiseachHealthcare company MSD Ireland has acquired the state-of -the art WuXoimanufacturing plant in Dundalk, with the official ...
US multinational pharmaceutical company MSD has today (6 January) announced the acquisition of WuXi Vaccines’ Dundalk site.
News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...
MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and ...
China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 ...
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback